A similar pattern was observed for OS and LSS, with de novo DLBCL having the highest survival (5-year OS and LSS of 59 and 68%, respectively) and t-LPL/WM (5-year OS and LSS of 33 and 45%, respectively) having the lowest survival. This evidence concerns the gene LPL and diffuse large B-cell lymphoma.